Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer's Disease: A Pilot Study.

Journal of Alzheimer's disease : JAD - 1 Jan 2020

Thordardottir Steinunn, Almkvist Ove, Johansson Charlotte, Zetterberg Henrik, Blennow Kaj, Graff Caroline

Abstract excerpt

BACKGROUND: YKL-40 and neurogranin are promising additional cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD) which reflect different underlying disease mechanisms. OBJECTIVE: To compare the levels of CSF YKL-40 and neurogranin between asymptomatic carriers of familial AD (FAD) mutations (MC) and non-carriers (NC) from the same families. Another objective was to assess changes in YKL-40 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Amyloid beta-Peptides

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers

Share to Chitinase-3-Like Protein 1

Share to Cognitive Dysfunction

Share to Disease Progression

Share to Pilot Projects

Share to tau Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 32568193
DOI: 10.3233/JAD-191261
PMCID: PMC7505010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer's Disease: A Pilot Study.PMID 32568193Read ↗

Cerebrospinal fluid biomarkers in Alzheimer's disease families with PSEN1 mutations.Semantic proximity Read ↗

Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's diseaseSemantic proximity Read ↗

The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in developmentSemantic proximity Read ↗

CSF neurogranin levels as a biomarker in Alzheimer’s disease and frontotemporal lobar degeneration: a cross-sectional analysisSemantic proximity Read ↗

Cerebrospinal Fluid Biomarkers in Familial Forms of Alzheimer's Disease and Frontotemporal Dementia.Semantic proximity Read ↗

Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine ApproachSemantic proximity Read ↗

The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease.Semantic proximity Read ↗

[Biomarkers in Alzheimer's disease].Semantic proximity Read ↗

Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical ADSemantic proximity Read ↗

YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer’s DiseaseSemantic proximity Read ↗

Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations.Semantic proximity Read ↗

Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-oldsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.